Taipei, Feb. 8 (CNA) Taiwan-based biotech firm OBI Pharma Inc. announced Tuesday that the COVID-19 vaccine it developed called BCVax will enter phase 1 & 2 clinical trials in the second half of this year.
High court upholds ruling in OBI Pharma insider trading case
01/26/2021 03:44 PM
A Taiwan High Court spokesperson holds a press conference on the ruling. CNA photo Jan. 26, 2021
Taipei, Jan. 26 (CNA) The Taiwan High Court on Tuesday upheld a lower court s not-guilty ruling in an insider trading case involving OBI Pharma Chairman Michael Chang (張念慈) and four other company executives.
The high court upheld the Shilin District Court s ruling in June 2019 that there was insufficient evidence showing that Chang, general manager Amy Huang (黃秀美), former vice chair Hsu Yo-gung (許友恭), research and development director Yu Cheng-te (游丞德) and administration division manager Liao Tsung-chih (廖宗智) committed insider trading.